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5 and 10 years of age, who were
brought to Germany by a humanitari-
an organization for surgery on severe
gun wounds to their lower extremities
(foot and thigh with chronic
osteomyelitis, respectively). To our
knowledge, these reports are the first
of cutaneous diphtheria in gunshot
wounds in recent years. Moreover, in
the patient with the thigh wound, C.
diphtheriae was also isolated from a
deep fistula, which suggests involve-
ment of C. diphtheriae in the chronic
osteomyelitis. 
As in the United Kingdom, all
cases of diphtheria reported since 1997
were caused by C. diphtheriae mitis. In
4 of 5 cutaneous diphtheria patients
who had an available medical history,
mixed infections with Staphylococcus
aureus and  Streptococcus pyogenes
were found; 3 of 5 patients were not
sufficiently vaccinated against diph-
theria as recommended. Systemic
symptoms, such as malaise and gener-
al weakness, developed in the 20-year-
old Thailand tourist, although she had
received a booster dose just before her
travel. Cutaneous diphtheria must be
expected even in vaccinated patients;
for instance, among serum samples of
287 healthy German adults with a
complete record of basic immuniza-
tion against diphtheria, only 42.2%
showed full serologic protection
as indicated by antitoxin levels
> 0.1 IU/mL (3).
As de Benoist et al. outline, cuta-
neous diphtheria might be difficult to
diagnose because of its unspecific
clinical appearance and the presence
of mixed infections in chronic
nonhealing skin lesions. Because of
the nearly complete disappearance of
cutaneous diphtheria in many parts of
the western world, microbiologists
lack experience in identifying C. diph-
theriae grown from specimens. From
1997 to 2003, approximately one fifth
of the strains sent to our Consiliary
Laboratory on Diphtheria for species
identification and toxin testing were
either nondiphtheria Corynebacterium
spp. or noncoryneform bacteria of dif-
ferent genera (including lactobacilli,
Dermabacter hominis, and
Propionibacterium acnes).
Clinicians (4) and microbiologists
(5) should be aware of the possibility
of cutaneous diphtheria in chronically
infected skin lesions in patients
returning from disease-endemic
regions. Medical personnel should
include this in civilian as well as mil-
itary health services, since our cases
indicate that toxigenic C. diphtheriae
might affect not only travel-related
skin injuries caused by leisure or
tourist activities but also wounds in
patients from war regions in diphthe-
ria-endemic areas.
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Antimicrobial Drug
Consumption in
Companion Animals 
To the Editor: During the last
decade, use of antimicrobial drugs for
growth promotion and therapeutic
treatment in food animals has received
much attention. The reservoir of resist-
ant bacteria in food animals implies a
potential risk for transfer of resistant
bacteria, or resistance genes, from
food animals to humans. Subsequent
emergence of infections in humans,
caused by resistant bacteria originat-
ing from the animal reservoir, is of
great concern. These unintended con-
sequences of antimicrobial drug use in
animals led to termination of antimi-
crobial growth promoters in food ani-
mals in countries in the European
Union, including Denmark, where the
consumption of antimicrobial drugs
by production animals was reduced by
50% from 1994 to 2003 (1).
In Denmark, the VetStat program
monitors all veterinary use of medi-
cines for animals. VetStat is based on
reporting from the pharmacies and
from veterinary practitioners and con-
tains detailed information, such as
animal species, reason for prescrip-
tion, and dosage on each prescription.
In Denmark, antimicrobial drugs can
be obtained only by prescription and
only at pharmacies. 
So far, use of antimicrobial drugs
in companion animals has received
little attention; monitoring programs
have focused on antimicrobial drug
consumption in food animals.
According to data generated by the
VetStat program in 2003, consump-
tion of fluoroquinolones and
cephalosporins in companion animals
was substantial when compared to
consumption in food animals (1).
Fluoroquinolones and cephalosporins
are antimicrobial drugs ranked by the
U.S. Food and Drug Administration
as critically important in human med-
icine, and for which emergence of
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resistant bacteria is especially unde-
sirable (2). Considering the shared
environment of humans and compan-
ion animals, transfer of resistant bac-
teria or mobile resistance determi-
nants from companion animals to
humans would be possible, and emer-
gence of resistance to fluoro-
quinolones and cephalosporins in
companion animals should be a mat-
ter of concern. 
Several scientific publications
have reported the occurrence of the
same resistance genes in companion
animals and in humans (3–6) and the
possible transfer of bacteria between
companion animals and humans
(3–9). Companion animal owners and
their families are likely in close con-
tact with their animals daily, which
provides the opportunity for transfer
of bacteria between companion ani-
mals and humans. A large proportion
of the human population presumably
has daily contact with companion ani-
mals, not only in Denmark but also in
other countries. In Denmark, 20% of
families own dogs and 16% own cats
(10). 
In 2002, legal restrictions aimed to
reduce the usage of fluoroquinolones
in food animals were imposed in
Denmark. The total annual consump-
tion of fluoroquinolones in animals
(companion and food animals) in
Denmark was reduced from 183 kg in
2001 to 53 kg in 2003 (1). Of these 53
kg of fluoroquinolones, almost half
(24 kg) was used in companion ani-
mals (data based on reporting on use
in veterinary practice and sales from
pharmacies on prescription). These
data document that fluoroquinolones
remain widely used for infections in
companion animals, even though the
emergence of fluoroquinolone resist-
ance in bacteria is especially undesir-
able and regarded as a human health
hazard. A similar situation exists with
cephalosporins. The total consump-
tion of cephalosporins in animals
(companion and food animals) in
Denmark in 2003 was 461 kg, of
which more than half (254 kg) was
consumed by companion animals (1).
Thus, a comparatively small num-
ber of companion animals (550,000
dogs and 650,000 cats) (10) consume
approximately the same amount of
fluoroquinolones and cephalosporins
as consumed annually in the much
larger population of food animals in
Denmark (23 million slaughter pigs,
130 million broiler chickens, and 1.2
million cattle and dairy cows) (10).
We do not believe that antimicrobial
drugs are more generously prescribed
for companion animals in Denmark
than in other industrialized countries.
Rather, the data presented here reflect
the apparent contrast between policies
of antimicrobial drug use for food ani-
mals and policies for companion ani-
mals. The use of these antimicrobial
drugs is avoided or restricted in food
animals to minimize spread of resist-
ance, while in companion animals
prescription continues unimpeded.
This situation may create undesirable
antimicrobial drug resistance in bacte-
ria, which may subsequently spread to
humans from the previously neglected
reservoir in companion animals. 
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